¼¼°èÀÇ µ¿¹°¿ë Á¦¼¼µ¿±â ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : ¸ð´Þ¸®Æ¼º°, ±â¼úº°, ±â´Éº°, µ¿¹°º°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹® ¿¹Ãø(2024-2030³â)
Veterinary Defibrillators Market Size, Share & Trends Analysis Report By Modality (Manual, Automatic), By Technology (Monophasic, Biphasic), By Functionality, By Animal, By End-use, By Region, And Segment Forecasts, 2024 - 2030
»óǰÄÚµå : 1571447
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2024³â 09¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,272,000
Unprintable PDF & Excel (Single User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» 1Àθ¸ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 6,950 £Ü 9,662,000
Printable PDF & Excel (5-User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» µ¿ÀÏ ±â¾÷ ³» µ¿ÀÏ ºÎ¼­¿¡¼­ ÃÖ´ë 5¸í±îÁö »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â °¡´ÉÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,443,000
Printable PDF & Excel (Enterprise License) help
º¸°í¼­ ±¸¸Å ±â¾÷ ¹× ±× ÀÚȸ»ç, °ü°è»ç°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀ̸ç, PDF ¹× ¿¢¼¿ ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

µ¿¹°¿ë Á¦¼¼µ¿±â ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ :

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ¼¼°è µ¿¹°¿ë Á¦¼¼µ¿±â ½ÃÀåÀº 2030³â±îÁö 9,999¸¸ ´Þ·¯¿¡ À̸£¸ç ¿¹Ãø ±â°£ µ¿¾È CAGR 5.66%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â µÎ °¡Áö Áß¿äÇÑ ¿ä¼Ò´Â °³¿Í °í¾çÀÌÀÇ ºÎÁ¤¸Æ »ç·Ê Áõ°¡¿Í ±ÔÁ¦ ÁöħÀÇ ÁøÈ­ÀÔ´Ï´Ù.

½É¹æ¼¼µ¿À̳ª ¹«¸Æ¼º ½É½Çºó¸Æ/½É½ÇÁ¶µ¿(PVT)°ú °°Àº ºÎÁ¤¸ÆÀº °³¿Í °í¾çÀÌÀÇ »ý¸íÀ» ±¸Çϱâ À§ÇØ Á¦¼¼µ¿ Ä¡·á°¡ ÇÊ¿äÇÑ Áúº´ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Áúº´ÀÇ °æ¿ì´Â ÃÖ±Ù ¸î ³âµ¿¾È Áõ°¡ÇÏ´Â °æÇâÀÌ ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 6¿ù¿¡ India Veterinary Journal¿¡ °ÔÀçµÈ ¿¬±¸´Â 1³â ÀÌ»ó, Áï 2022³â 7¿ùºÎÅÍ 2023³â 9¿ù±îÁö °³ ºÎÁ¤¸ÆÀÇ À¯º´·üÀ» Æò°¡ÇÕ´Ï´Ù. ÀÌ¿¡ µû¸£¸é °³ÀÇ ºÎÁ¤¸Æ À¯º´·üÀº 26.21% ÀÌ»ó, ½É¹æ¼¼µ¿Àº 30.70% ÀÌ»óÀ̾ú½À´Ï´Ù. ÀÌ ºÎÁ¤¸ÆÀÇ À¯º´·üÀº °³ ³ªÀÌ¿Í °³Á¾¿¡ µû¶ó ´Ù¸¨´Ï´Ù.

°Ô´Ù°¡ 2023³â 8¿ù Journal of Veterinary Emergency and Critical Care¿¡ °ÔÀçµÈ ¿¬±¸¿¡¼­´Â ¼¼°è 16°³ µ¿¹°º´¿ø¿¡¼­ °³¿Í °í¾çÀÌÀÇ ½ÉÆóÁ¤Áö(CPA) 627·Ê¸¦ ºÐ¼®ÇÏ¿© ½ÉÁ¤Áö ¸®µëÀÇ À¯º´·ü ±×¸®°í »ýÁ¸ °á°ú¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ ÁßÁ¡À» µÓ´Ï´Ù. ù ¹øÂ° Ãæ°Ý °¡´ÉÇÑ ¸®µë(I-SHKR)Àº µå¹°¸ç °³ 4%, °í¾çÀÌ 5%¿¡¼­ ¹ß°ßµÇ°í, ÈÄ¼Ó Ãæ°Ý °¡´ÉÇÑ ¸®µë(S-SHKR)Àº °³ 15%, °í¾çÀÌ´Â 5%¸¦ º¸¿´½À´Ï´Ù. Ãæ°Ý °¡´ÉÇÑ ¸®µë°ú Ãæ°ÝÀÌ ºÒ°¡´ÉÇÑ ¸®µë »çÀÌ¿¡¼­ ÀÚ¿¬ ¼øÈ¯ º¹±Í(ROSC) ºñÀ²¿¡ À¯ÀÇ ÇÑ Â÷ÀÌ´Â ¾ø½À´Ï´Ù. ÀÌ ¿¬±¸´Â »ýÁ¸À²À» Çâ»ó½Ã۱â À§ÇØ ¿¬±¸¿Í °°Àº Ç¥ÁØÈ­µÈ CPR ÁöħÀ» ÀϰüµÇ°Ô ÁؼöÇÏ´Â °ÍÀÌ Áß¿äÇÔÀ» °­Á¶ÇÏ°í µ¿¹° »ýÁ¸¿¡¼­ ÀÌ·¯ÇÑ ¸®µëÀÇ ¿ªÇÒÀ» ´õ Àß ÀÌÇØÇϱâ À§ÇØ Ãß°¡ ¿¬±¸¸¦ Ãß±¸ÇÕ´Ï´Ù.

¹Ì±¹ ¼öÀÇ»çȸ(AVMA)´Â 2024³â 7¿ù °³ °í¾çÀÌÀÇ ½ÉÆó ¼Ò»ý(CPR) ÁöħÀ» °³Á¤Çß½À´Ï´Ù. ÀÌ Áß¿äÇÑ ¾÷µ¥ÀÌÆ®´Â "ȹÀÏÀûÀÎ" Á¢±Ù¹ýÀ» Æ÷±âÇÏ°í °¢ µ¿¹° Á¾¿¡ ƯÁ¤ÇÑ ¿ä±¸ »çÇ×À» °í·ÁÇѺ¸´Ù °³º°È­ µÈ °èȹÀ» äÅÃÇϰԵǾú½À´Ï´Ù. ¾÷µ¥ÀÌÆ®µÈ °¡À̵å¶óÀÎÀº ½Å¼Ó¼ºÀÇ °¡Ä¡¸¦ °­Á¶Çϰí Á¦¼¼µ¿, ÀΰøÈ£Èí, ½Å¼ÓÇÑ Èä°ñ¾Ð¹ÚÀÌ ±¸¸íÀ» ÀÌ·ç´Â Áß¿äÇÑ ¿ªÇÒÀ» °­Á¶ÇÕ´Ï´Ù. ÀÌ °¡À̵å¶óÀÎÀº ¼¼°è °øÅë CPR ¾Ë°í¸®ÁòÀ» µµÀÔÇÏ¿© ´Ù¾çÇÑ ½Ã³ª¸®¿À¿¡¼­ Àϰü¼ºÀ» È®º¸ÇÏ°í ¼öÀǻ簡 ±ä±Þ »óȲ¿¡ È¿°úÀûÀ¸·Î ´ëÀÀÇÒ ¼ö ÀÖµµ·Ï ÇÕ´Ï´Ù. ÃֽŠÁöħÀº ½ÉÆó ¼Ò»ý Áß ÆÀ¿öÅ©¿Í ÀÇ»ç ¼ÒÅëÀ» °­Á¶Çϰí ÀÖÀ¸¸ç, °¡Àå È¿°úÀûÀÎ °á°ú¸¦ ¾òÀ¸·Á¸é ¿øÈ°ÇÑ Çù·ÂÀÌ ÇʼöÀûÀÓÀ» ÀÎÁ¤ÇÕ´Ï´Ù.

±×·¯³ª ÀÌ ½ÃÀåÀÇ ¼ºÀåÀ» ¹æÇØÇÏ´Â Áß¿äÇÑ ¿ä¼Ò Áß Çϳª´Â µ¿¹° Á¦¼¼µ¿±âÀÇ Á¶´ÞÀÌ ÇÑ ³ª¶ó¿¡ ÀÇÁ¸ÇÑ´Ù´Â °ÍÀÔ´Ï´Ù. µ¿¹° Á¦¼¼µ¿±â¸¦ Á¦Á¶ÇÏ´Â ´ëºÎºÐÀÇ Á¦Á¶ ¾÷ü´Â Áß±¹¿¡ º»»ç¸¦µÎ°í ÀÖ½À´Ï´Ù. Kalstein(ÇÁ¶û½º), New Gen Medical Systems ¹× Digicare Biomedical°ú °°Àº ¼Ò¼öÀÇ Á¦Á¶¾÷ü¸¦ Á¦¿ÜÇÏ¸é ¼¼°è ¼ÒºñÀÚ´Â Áß±¹ Á¦Á¶¾÷ü¿¡ Å©°Ô ÀÇÁ¸ÇÕ´Ï´Ù. °ø±Þ¸ÁÀÇ È¥¶õÀ̳ª ±âŸ ¿äÀÎÀÌ ¹ß»ýÇϸé ÀÌ·¯ÇÑ ÀÇÁ¸¼ºÀº ½ÃÀå¿¡ ÇØ·Î¿ï ¼ö ÀÖ½À´Ï´Ù.

µ¿¹°¿ë Á¦¼¼µ¿±â ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå µ¿¹°¿ë Á¦¼¼µ¿±â ½ÃÀåÀÇ º¯µ¿ µ¿Çâ°ú ¹üÀ§

Á¦4Àå µ¿¹°¿ë Á¦¼¼µ¿±â ½ÃÀå : µ¿¹°ÀÇ ÃßÁ¤ ¹× µ¿Ç⠺м®

Á¦5Àå µ¿¹°¿ë Á¦¼¼µ¿±â ½ÃÀå : ¸ð´Þ¸®Æ¼ÀÇ ÃßÁ¤ ¹× µ¿Ç⠺м®

Á¦6Àå µ¿¹°¿ë Á¦¼¼µ¿±â ½ÃÀå : ±â¼úÀÇ ÃßÁ¤ ¹× µ¿Ç⠺м®

Á¦7Àå µ¿¹°¿ë Á¦¼¼µ¿±â ½ÃÀå : ±â´ÉÀÇ ÃßÁ¤ ¹× µ¿Ç⠺м®

Á¦8Àå µ¿¹°¿ë Á¦¼¼µ¿±â ½ÃÀå : ÃÖÁ¾ ¿ëµµÀÇ ÃßÁ¤ ¹× µ¿Ç⠺м®

Á¦9Àå µ¿¹°¿ë Á¦¼¼µ¿±â ½ÃÀå : ±¹°¡ÀÇ ÃßÁ¤ ¹× µ¿Ç⠺м®, ¼½Åͺ°, ¼ÒÇÁÆ®¿þ¾îº°, ¸ð´Þ¸®Æ¼º°, ¿ëµµº°

Á¦10Àå °æÀï ±¸µµ

Á¦11Àå Áß¿äÇÑ Æ÷ÀÎÆ®

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Veterinary Defibrillators Market Growth & Trends:

The global veterinary defibrillators market is expected to reach USD 99.99 million by 2030 and is anticipated to register a CAGR of 5.66% over the forecast period, according to a new report by Grand View Research, Inc. Two crucial factors driving the market growth are rising cases of arrhythmia in dogs & cats and evolving regulatory guidelines.

Arrhythmias like atrial fibrillation and Pulseless Ventricular Tachycardia/Ventricular Flutter (PVT) are the conditions that require defibrillation treatment to save the lives of dogs and cats. The cases of these conditions have been on the rise in recent years. For instance, a June 2024 study published in India Veterinary Journal evaluated the prevalence of arrhythmias in dogs for over a year, i.e., July 2022 to September 2023. According to this report, the prevalence of arrhythmias was found to be at over 26.21% in dogs and that of atrial fibrillation at over 30.70%. The prevalence of these arrhythmias in dogs varied with their ages and breeds.

Furthermore, an August 2023 study published in the Journal of Veterinary Emergency and Critical Care analyzed 627 cases of cardiopulmonary arrest (CPA) in dogs and cats across 16 veterinary institutions globally, focusing on the prevalence and impact of cardiac arrest rhythms on survival outcomes. Initial shockable rhythms (I-SHKRs) were rare, occurring in 4% of dogs and 5% of cats, with subsequent shockable rhythms (S-SHKRs) in 15% of dogs and 5% of cats. No significant differences in return of spontaneous circulation (ROSC) rates were found between shockable and non-shockable rhythms. The study underscores the importance of consistent adherence to standardized CPR guidelines, like RECOVER, to improve survival rates and calls for further research to better understand these rhythms' role in animal survival.

The American Veterinary Medical Association (AVMA) revised its cardiopulmonary resuscitation (CPR) guidelines for cats and dogs in July 2024. With this important update, the "one-size-fits-all" approach is abandoned in favor of a more individualized plan that takes into account the particular requirements of each species. The updated guidelines emphasize the value of quickness and stress the vital role that defibrillation, ventilation, and quick chest compressions play in saving lives. The guidelines ensure consistency in various scenarios by implementing a universal CPR algorithm, which facilitates veterinarians' ability to respond effectively in emergencies. The updated guidelines additionally stress teamwork and communication more during CPR, realizing that smooth cooperation is essential to getting the most effective outcomes.

However, one crucial factor that might hamper the growth of this market is its dependance on a single country for procuring veterinary specific defibrillators. Majority of the manufacturers that produce these defibrillators for veterinary use are headquartered in China. Apart from a handful of other players like Kalstein (France), New Gen Medical Systems and Digicare Biomedical, the consumers across the world are heavily dependent on the Chinese manufacturers. In case of events such as supply chain disruptions and other factors, this dependence may prove to be harmful for the market.

Veterinary Defibrillators Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Veterinary Defibrillators Market Variable Trends & Scope

Chapter 4. Veterinary Defibrillators Market: Animal Estimates & Trend Analysis

Chapter 5. Veterinary Defibrillators Market: Modality Estimates & Trend Analysis

Chapter 6. Veterinary Defibrillators Market: Technology Estimates & Trend Analysis

Chapter 7. Veterinary Defibrillators Market: Functionality Estimates & Trend Analysis

Chapter 8. Veterinary Defibrillators Market: End Use Estimates & Trend Analysis

Chapter 9. Veterinary Defibrillators Market: Country Estimates & Trend Analysis, by Sector, Software, Modality & Application

Chapter 10. Competitive Landscape

Chapter 11. Key Takeaways

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â